Clinical Trials Browser

Phase 2 × INDUSTRY × Endocrine × Clear all

von Hippel-Lindau Disease, Adenoma, Islet Cell, Paraganglioma, Pheochromocytoma

NCT02568267 2026-05-27

STARTRK-2

BreastCNSDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidNETSarcomaThoracic

Thyroid Cancer, Papillary, Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Colorectal Neoplasms, Lymphoma, Large-Cell, Anaplastic, Cholangiocarcinoma, Neuroendocrine Tumors

NCT03604198 2026-04-21

Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome

Phase 2 Active not recruiting

125 enrolled

Endocrine

ACTH Syndrome, Ectopic, Adrenal Cortex Neoplasms, Cushing Syndrome, Diabetes Mellitus, Type 2, Hypertension, Adrenocortical Carcinoma, Pituitary ACTH Hypersecretion

NCT05153772 2026-04-15

ALPHAMEDIX02

Phase 2 Active not recruiting

69 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT06502977 2026-04-15

DeLLphi-307

Phase 2 Active not recruiting

32 enrolled 9 charts

EndocrineNET

Neoplasms, Neuroendocrine Tumors

Clinical Trials

MK-6482-015

STARTRK-2

Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome

ALPHAMEDIX02

DeLLphi-307

Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma

NETTER-P

Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors

RESCUE

Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors

KEYNOTE 158

Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer

Open-Label Surufatinib in European Patients With NET

Study of ZG006 in Participants With Neuroendocrine Prostate Cancer

RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)

A Diagnostic Imaging Study of 64Cu-SARTATE Using PET on Patients With Known or Suspected Neuroendocrine Tumors (DISCO)

18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System

A Study of PM8002 in Combination With Chemotherapy in Patients With NEN

Milademetan in Advanced/Metastatic Solid Tumors

A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET)

Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors

DTC

Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers

ALpha-T

Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Pituitary Tumors

CLARINET FORTE

TheraSphere for the Treatment of Liver Metastases

LUNA

Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)

To Evaluate the Optimal Dose of 68Ga-OPS202 as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)

Efficacy and Safety of Lanreotide Autogel in Tumour Stabilization of Patients With Progressive Neuroendocrine Tumours

Study of HX008 for the Treatment of Anaplastic Thyroid Cancer (ATC)

ATLANT

Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease

A Study of Anlotinib and AK105 Injection in Subjects With Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine Tumors

TBR-760 in Adult Patients With Non-Functioning Pituitary Adenomas

A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma

A Phase 2 Trial of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer (ATC)

Study to Evaluate CORT125134 in Participants With Cushing's Syndrome

A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer

Efficacy and Safety of Pasireotide LAR (Long-acting Release) in Japanese Patients With Acromegaly or Pituitary Gigantism

SONNET

Passion I

Phase 2 Trial of Donafenib in 131I-Refractory Differentiated Thyroid Cancer

RAMSETE/CDE16

A Study of Famitinib in Patients With Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumor

Safety and Efficacy of VB-111 in Subjects With Advanced Differentiated Thyroid Cancer

A Study of Anlotinib in Patients With Gastroenteropancreatic Neuroendocrine Tumor G3